Feb 27 |
Rocket (RCKT) Registers Narrower-Than-Expected Loss in Q4
|
Feb 26 |
Rocket Pharmaceuticals GAAP EPS of -$0.64 beats by $0.14
|
Feb 26 |
Rocket Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Highlights Recent Progress
|
Feb 13 |
15 Best Strong Buy Stocks To Invest In
|
Feb 13 |
FDA extends review period for Rocket gene therapy to June 30
|
Feb 13 |
Rocket Pharmaceuticals Announces Update on FDA Review Timeline of KRESLADI™ (marnetegragene autotemcel) for the Treatment of Severe Leukocyte Adhesion Deficiency-I (LAD-I)
|
Jan 23 |
7 Speculative Stocks to Double Your Money THIS Year
|
Jan 22 |
Should You Maintain Your Conviction in Rocket Pharmaceuticals (RCKT)?
|
Jan 18 |
Rocket Pharmaceuticals, Inc.'s (NASDAQ:RCKT) Shift From Loss To Profit
|
Jan 2 |
Rocket Pharmaceuticals to Present at 42nd Annual J.P. Morgan Healthcare Conference
|